Concentrix (CNXC) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
27 Feb, 2026Executive summary
Supplement issued to address a stockholder demand regarding disclosure on voting treatment for Proposal No. 4 at the March 25, 2026 Annual Meeting.
Company asserts the original omission was immaterial but provides additional disclosure to avoid potential delays or distractions.
No other changes to the proxy statement beyond the supplemental disclosure.
Voting matters and shareholder proposals
Proposal No. 4 concerns amending the 2020 Stock Incentive Plan to increase shares available for issuance.
Approval requires a majority of shares represented and entitled to vote, with abstentions counted as votes against and broker non-votes having no effect.
Proxies submitted without direction will be voted in favor of the amendment.
Shareholder rights and capital structure
Clarifies voting mechanics for Proposal No. 4, specifying the impact of abstentions and broker non-votes on the outcome.
Latest events from Concentrix
- All voting items, including director elections and stock plan amendment, were approved.CNXC
AGM 202626 Mar 2026 - Q1 revenue up 5.4% to $2.5B, with strong AI growth but lower margins and net income.CNXC
Q1 202624 Mar 2026 - Key votes include director elections, auditor ratification, and stock plan amendment.CNXC
Proxy Filing13 Feb 2026 - 2026 meeting covers board elections, auditor, pay, and equity plan amid strong governance and ESG.CNXC
Proxy Filing13 Feb 2026 - Q2 revenue up 47.4% to $2.38B; guidance raised despite net income decline on higher costs.CNXC
Q2 20243 Feb 2026 - Q1 growth strong, Webhelp integration on track, and generative AI seen as a major opportunity.CNXC
BofA Securities 2024 Global Technology Conference1 Feb 2026 - Revenue up 46% to $2.4B, but net income dropped to $16.6M on integration costs.CNXC
Q3 202420 Jan 2026 - Record revenue and cash flow in 2025 set the stage for further growth in 2026.CNXC
Q4 202513 Jan 2026 - FY24 revenue hit $9.62B with strong cash flow; FY25 set for margin and cash flow growth.CNXC
Q4 202410 Jan 2026